In vivo restoration of RhoB expression leads to ovarian tumor regression. (Q40002462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

title

In vivo restoration of RhoB expression leads to ovarian tumor regression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

Ben Allal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

Justin Teissie

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

Gilles Favre

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

author name string

B Couderc

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

A Pradines

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

A Rafii

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

M Golzio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

D Berg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

M Penary

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

publication date

14 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

456-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18340357 AND SRC:MED&resulttype=core&format=json

Control of vesicular trafficking by Rho GTPases

4 January 2020

cites work

1 reference

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

21 January 2018

Rho proteins and cancer

1 reference

Loss of RhoB expression in human lung cancer progression.

21 January 2018

1 reference

Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells

21 January 2018

1 reference

RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells

21 January 2018

1 reference

21 January 2018

1 reference

RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors

21 January 2018

1 reference

RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage

21 January 2018

1 reference

Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis

21 January 2018

1 reference

Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line

21 January 2018

1 reference

The expression of rho proteins decreases with human brain tumor progression: potential tumor markers

21 January 2018

1 reference

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

21 January 2018

1 reference

WWOX gene restoration prevents lung cancer growth in vitro and in vivo

21 January 2018

1 reference

Detection and clinical importance of micrometastatic disease

21 January 2018

1 reference

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

21 January 2018

1 reference

Why did p53 gene therapy fail in ovarian cancer?

21 January 2018

1 reference

Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status

21 January 2018

1 reference

Differentiation and assessment of cell death

21 January 2018

1 reference

Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity

21 January 2018

1 reference

RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells

21 January 2018

1 reference

Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.

21 January 2018

1 reference

Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

1 reference